No Data
No Data
Analysts Have Been Trimming Their Apyx Medical Corporation (NASDAQ:APYX) Price Target After Its Latest Report
Apyx Medical | 10-Q: Quarterly report
Express News | Stavros G. Vizirgianakis: On May 7, Stavros Vizirgianakis Entered Into a Letter Agreement With Apyx
Express News | Apyx Medical Sees FY24 Revenues Of $49.7M-$52.9M Vs. $49.94M Estimate, Representing Decrease Of Approximately 5% Compared To Growth Of Approximately 1% YoY
Apyx Medical Sees FY24 Rev $49.7M-$52.9M >APYX
Apyx Medical Sees FY24 Rev $49.7M-$52.9M >APYX
Express News | Apyx Medical Corp Q1 Shr View $-0.21 -- Lseg Ibes Data
JESSE JAMES8832OP : bottom watch
zainong : How come ah